Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)
Meeting Abstract
Holloway, R. W.; Mendivil, A. A.; Kendrick, J. E.; Abaid, L. N.; Brown, J. V.; Fitzsimmons, C. K.; Kennard, J. A.; King, M.; LeBlanc, J.; Lopez, K.; Manyam, M.; McKenzie, N. D.; Mori, K. M.; Stephens, A. J.; Ahmad, S.